Monitor completion of remaining 32 clinic lease assignments over the coming weeks—delays could signal execution risk. The shift to a pure franchisor model will reduce corporate revenue but potentially improve margin profile. Watch for Q2 2026 earnings for initial financial impact from the transaction.
Price Chart
Executive Summary
Joint Corp announced the sale of 45 company-owned/managed clinics in Southern California to Elite Chiro Group for $2.3 million, with 13 clinics closed immediately and 32 under a management service agreement pending lease assignments. The transaction reduces corporate clinics to just 3 out of 960 total locations, marking a significant step toward becoming a pure-play franchisor.
Key Facts
- Sale of 45 corporate managed clinics for aggregate purchase price of $2.3 million
- 13 clinics closed on April 27, 2026; remaining 32 under Management Service Agreement until lease assignments
- Corporate-managed clinics expected to reduce to just 3 out of 960 total locations after completion
- Transaction positions The Joint as a capital-light, pure-play franchisor model
Financial Impact
Sale price of $2.3 million, representing approximately 1.8% of $127M market cap
Risk Factors
- Failure to obtain lease assignments for remaining 32 clinics could delay or reduce total consideration
- Transition to franchisor model may reduce near-term revenue from sold clinics
- Execution risk in refranchising the final 3 corporate clinics
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001612630-26-000039 |
| Document: a26-04x27jyntrelease.htm | 0001612630-26-000039 |
| Document: 0001612630-26-000039-index-headers.html | 0001612630-26-000039 |
| Document: 0001612630-26-000039-index.html | 0001612630-26-000039 |
| Document: 0001612630-26-000039.txt | 0001612630-26-000039 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | Press Release | $7.37 | awaiting T+20 | — | $7.28 (−1.22%) |
Oct 1, 2026 25d ago | 8-K | $7.47 | awaiting T+20 | — | $7.28 (−2.54%) |
May 1, 2026 25w ago | 8-K | $8.79 $8.57 | ▼ −2.50% | ▼ −8.15% | $7.28 (−17.18%) |
Apr 24, 2026 26w ago | 8-K | $9.08 $9.22 | ▲ +1.54% | ▼ −3.41% | $7.28 (−19.82%) |
Apr 23, 2026 26w ago | Press Release | $8.80 $8.75 | ▼ −0.57% | ▼ −5.20% | $7.28 (−17.27%) |
Apr 7, 2026 28w ago | DEFA14A | $8.93 $8.64 | ▼ −3.25% | ▼ −11.79% | $7.28 (−18.48%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers